Urinary Incontinence
📧 Sign up to get email alerts when something new happens for Urinary Incontinence.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-05-29FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for OXYTROL (oxybutynin), the transdermal patch from Allergan, Inc., signifying approval of updated …
-
FDA approval · 2013-03-15FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for OXYTROL (oxybutynin) submitted by Allergan, Inc.
-
FDA approval · 2013-01-25FDA Approved: OXYTROL FOR WOMEN — Original Application (Allergan, Inc.)
The FDA approved OXYTROL FOR WOMEN (oxybutynin) under Allergan's original application. It is indicated for urinary symptoms associated with …
-
FDA approval · 2012-11-30FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for trospium chloride submitted by Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2012-10-10FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's OXYTROL (oxybutynin) supplemental application, enabling a label modification for the product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-08-01FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for tolterodine tartrate submitted by Mylan Pharmaceuticals Inc. under NDA 020771. The drug is a tre…
-
FDA approval · 2012-06-13FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for oxybutynin chloride submitted by Strides Pharma Science Limited.
-
FDA approval · 2012-06-13FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for oxybutynin chloride filed by Teva Pharmaceuticals USA, Inc., encompassing a labeling change thro…
-
FDA approval · 2012-05-31FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for trospium chloride filed by Glenmark Pharmaceuticals Inc., USA, supporting a labeling change …
-
FDA approval · 2012-04-26FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for oxybutynin chloride from Upsher-Smith Laboratories, likely updating labeling or indications.
-
FDA approval · 2012-04-26FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for oxybutynin chloride from Strides Pharma Science Limited. This action approves the generic pr…
-
FDA approval · 2011-10-28FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for oxybutynin chloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2011-09-20FDA Approved: DETROL LA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DETROL LA (tolterodine tartrate) from Viatris Specialty LLC.
-
FDA approval · 2011-03-31FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Trospium chloride from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2010-09-20FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for oxybutynin chloride from Lannett Company, granting approval of a generic version of the drug…
-
FDA approval · 2010-04-07FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for oxybutynin chloride filed by Chartwell RX, LLC.
-
FDA approval · 2010-03-09FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for oxybutynin chloride from Teva Pharmaceuticals USA, updating the product labeling.
-
FDA approval · 2010-03-09FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for oxybutynin chloride from Strides Pharma Science Limited.
-
FDA approval · 2010-03-03FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for oxybutynin chloride from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2009-04-08FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for tolterodine tartrate filed by Mylan Pharmaceuticals Inc. under NDA 020771.
-
FDA approval · 2009-01-06FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved the supplemental application for oxybutynin chloride submitted by Strides Pharma Science Limited. The approval covers changes a…
-
FDA approval · 2008-09-11FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for tolterodine tartrate filed by Mylan Pharmaceuticals Inc.
-
FDA approval · 2007-04-24FDA Approved: VESICARE — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for Vesicare (solifenacin succinate) from Astellas Pharma US, Inc. under NDA 021518.
-
FDA approval · 2007-03-16FDA Approved: DETROL LA — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for DETROL LA (tolterodine tartrate) from Viatris Specialty LLC.
-
FDA approval · 2007-03-16FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for tolterodine tartrate submitted by Mylan Pharmaceuticals Inc., updating the product's labelin…